Abstract:

Since 1990, healthcare systems in advanced nations have been degrading rapidly, with rising costs, rampant chronic diseases, and aging demographics. In response, governments and private sectors have been seeking solutions from untapped fields, such as the 47-century old Traditional Chinese Medicine (TCM). TCM is based on the conceptual theory of qi (or chi) stating that the vitality of human body relies on adequate qi continuously circulating and permeating throughout the entire body. Today, TCM is included in the national health care systems of major countries in East Asia, used by 60-75% of the populations. Elsewhere TCM operations are still in back alleys. TCM’s dilemma is rooted in its inability to meet the standards of science and evidence-based modern medicine. In 2018, this author began to develop the scientific theory of Chee and its field equations based on modern sciences. (“Chee” was coined to differentiate from the commonly used “qi.”) TCM procedures were distilled and synthesized, one by one, to metamorphose TCM to Scientific TCM (STCM). Theoretical results were presented in four IEEE international symposiums and published in a medical journal during 2022-2023. Our empirical validation and preliminary characterization of Chee succeeded on November 25, 2024—for the first time—in spite of research efforts worldwide since 1978. Our success mainly stems from the use of spectral technology and modulation technique as Chee is a tiny biomarker emitted by neurons thus at very low frequencies. Our findings on Scientific TCM and validations on the theory of Chee and Chee as a modulated biomarker are giving rise to new and fundamental visions for biology, physiology, and psychology, which should have broad impacts on diagnosis, treatment, and prevention of diseases, allergies, cancers, among others.